Loading...
Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial
Limited information is available on the clinical course of patients with severe asthma following discontinuation of biologic treatment. Therefore, a post hoc analysis was conducted in patients with severe eosinophilic asthma who participated in the COSMOS trial, where patients received mepolizumab f...
Na minha lista:
| Udgivet i: | Allergy Asthma Clin Immunol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558891/ https://ncbi.nlm.nih.gov/pubmed/31198427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-019-0348-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|